.
.
Application deadline: 07 June 2021
This new virtual course has been designed for transplant surgeons and nephrologists with an interest in deceased donor kidney transplantation. This will be the first course in the UK dedicated to organ utilisation issues.
Decisions on whether to accept or decline a deceased donor kidney transplant offer, and who best to implant an organ into, are challenging and complex. This course aims to provide a framework and evidence-base in how to approach these decisions.
The course will be hosted by clinicians from Guy’s & St Thomas’ NHS Foundation Trust (GSTT): Mr Chris Callaghan (consultant transplant surgeon), Mr Jonathon Olsburgh (consultant transplant surgeon) and Dr Rachel Hilton (consultant nephrologist). They will be joined by other consultants from the Trust and across the UK.
For general queries or booking information, please contact Shaleem Grant (shaleem.grant@kcl.ac.uk).
For queries on course content, speaker and any other academic concerns, please contact Mr Chris Callaghan (Chris.Callaghan@gstt.nhs.uk).
For more details on the programme, fees and application, please visit:
.
MiCo Convention Centre, Milan, Italy
Registration for the ESOT Congress 2021 in Milan is now open, with discounted “early bird” pricing available until 11 May 2021.
Join the 20th edition of the European Society for Organ Transplantation’s (ESOT) biennial congress! The health and safety of Congress attendees is our first and foremost priority. We are taking a number of precautions to ensure the meeting will be a safe place for delegates to join us in-person in Milan. More information on these measures can be found here.
In addition, by utilising the very best technical solutions and live streaming, we will also be able to bring the Congress to delegates wherever they are in the world, offering a truly hybrid experience
.
.
The conference organisers are currently working on a fully virtual e-conference which will fulfil the aim to deliver an excellent scientific and educational programme.
All delegates will have access to the live conference in April, with the full conference material then available as catch up until April 2022 to include sessions, posters and exhibitor area.
Registration is now open!
• If you had already registered for EFI 2020/2021 you will have been contacted separately to transfer your booking to the online conference.
• If you are still to register your place visit: http://www.efi2021.org.uk/
More details, to include late-breaker abstract submission information and the programme will be available online soon.
To be kept up to date please join our mailing list.
.
We will share new scientific developments and techniques amongst scientists in the field, and benchmark outcomes and results across European centres involved in clinical pancreas and islet transplantation.
The Symposium is the largest meeting in Europe where experts in the field of pancreas and islet transplantation can get together to share experience and outcomes. It is such a small niche area this meeting is critical to the working objectives of exerts in the field.
Given the current circumstances, the Symposium will be presented as an online event.
This format offers a much broader global access to the event, and we look forward to welcoming new participants from the islet and pancreas community.
Recordings of these webinars are now available on demand on the ESOT’s YouTube channel.
The COVID-19 webinar series is supported by an unrestricted grant from Chiesi
.
.
As we face the second wave of the COVID-19 pandemic, questions around equity of access to transplantation are becoming more important than ever. The programme will incorporate the Hoffenberg Memorial Lecture, and will examine issues including:
The meeting will be run using the Zoom platform. Please see participant guidelines to ensure the best audience experience.
.
The programme will be delivered to you using a bespoke studio and on-line platform so that you can enjoy interactive plenary sessions in a studio environment, on-line parallel sessions and catch-up with content you have missed ‘on-demand’ – all included in your registration.
.
The registration for the next diet of purely online degree in Clinical Renal Transplantation at University of Liverpool is open now.
The programme commences on Monday 19th October 2020. This programme awards Postgraduate Certificate (PGCert), Postgraduate Diploma (PGDip) and Master Degree (MSc) in Organ Transplantation suitable for nephrologists, surgeons and any related specialities. In order to register, you will need to submit an application form, copy of qualifications, evidence of experience and first instalment of fee.
English language exam (IELTS) is NOT required for the entire programme (the whole MSc) for students who studied medicine in English.
For any enquiry, please contact us at:
ahmed.halawa@liverpool.ac.uk
For more details on the programme, fees and application, please visit the University of Liverpool website.
.
During the COVID-19 pandemic, transplant patients and clinicians have been faced with considerable challenges. In particular, immunosuppressed HBV liver transplant patients are required to receive on-going therapy to prevent HBV recurrence. To achieve comprehensive protection, it is recommended that patients, particularly those in the high-risk category, are administered a combination of antivirals and Hepatitis B-specific hyperimmunoglobulins (HBIG).
The intravenous and intramuscular administration of HBIG requires HBV liver transplant patients to visit the hospital and infusion ward, meaning patients are exposed to the risk of contracting COVID-19 through increased contact with both healthcare professionals, care-givers and other patients.
Subcutaneous administration offers an alternative option that allows the patient to administer HBIG by themselves at home. This ensures the patient receives essential medication without coming in to contact with others, which both reduces the patients’ risk of exposure to COVID-19 and allows healthcare professionals to focus on COVID-19 patients. Moreover, with therapy from home, comes greater flexibility and freedoms which increases compliance and quality of life for the patient.
ESOT, together with BIOTEST, is organising this webinar to discuss how immunosuppressed transplant patients can be kept safe from HBV-reinfection and COVID-19, whilst enjoying an improved quality of life, through self-administration of subcutaneous HBIG at home.
Join us and panellists Professor Jean Hardwigsen and Dr Riccardo Volpesto learn more.
.
